Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386558828> ?p ?o ?g. }
- W4386558828 endingPage "4470" @default.
- W4386558828 startingPage "4470" @default.
- W4386558828 abstract "Randomized clinical trials assessing the efficacy of neoadjuvant chemotherapy (NACT) for advanced epithelial ovarian cancer have predominantly included women with high-grade serous carcinomas. The response rate and oncological outcomes of NACT for malignant ovarian germ cell tumors (MOGCT) are poorly understood. This study aimed to examine the effects of NACT on women with MOGCT by conducting a systematic review of four public search engines. Fifteen studies were identified, and a further descriptive analysis was performed for 10 original articles. In those studies, most women were treated with a bleomycin, etoposide, and cisplatin regimen, and one to three cycles were used in most studies. Four studies comparing NACT and primary debulking surgery showed similar complete response rates (n = 2; pooled odds ratio [OR] 0.90, 95% confidence interval [CI] 0.15–5.27), comparable overall survival (n = 3; 87.0–100% versus 70.0–100%), disease-free survival (n = 3; 87.0–100% versus 70.0–100%), recurrence rate (n = 1; OR 3.50, 95%CI 0.38–32.50), and adverse events rate from chemotherapy between the groups. In conclusion, NACT may be considered for the management of MOGCT; however, possible candidates for NACT use and an ideal number of NACT cycles remain unknown. Further studies are warranted to validate the efficacy of NACT in advanced MOGCT patients." @default.
- W4386558828 created "2023-09-09" @default.
- W4386558828 creator A5004882510 @default.
- W4386558828 creator A5015116660 @default.
- W4386558828 creator A5019463160 @default.
- W4386558828 creator A5030516215 @default.
- W4386558828 creator A5044033060 @default.
- W4386558828 creator A5049884816 @default.
- W4386558828 creator A5052597738 @default.
- W4386558828 creator A5054335379 @default.
- W4386558828 creator A5071731375 @default.
- W4386558828 creator A5087796447 @default.
- W4386558828 creator A5090684583 @default.
- W4386558828 creator A5092829635 @default.
- W4386558828 date "2023-09-08" @default.
- W4386558828 modified "2023-10-17" @default.
- W4386558828 title "Systematic Review of the Survival Outcomes of Neoadjuvant Chemotherapy in Women with Malignant Ovarian—An Germ Cell Tumors" @default.
- W4386558828 cites W1551534581 @default.
- W4386558828 cites W1999748112 @default.
- W4386558828 cites W2006899747 @default.
- W4386558828 cites W2026595034 @default.
- W4386558828 cites W2053825811 @default.
- W4386558828 cites W2056596826 @default.
- W4386558828 cites W2088686331 @default.
- W4386558828 cites W2105967792 @default.
- W4386558828 cites W2106767659 @default.
- W4386558828 cites W2117805512 @default.
- W4386558828 cites W2126766697 @default.
- W4386558828 cites W2127113877 @default.
- W4386558828 cites W2156098321 @default.
- W4386558828 cites W2168893449 @default.
- W4386558828 cites W2198939776 @default.
- W4386558828 cites W2225316448 @default.
- W4386558828 cites W2301049944 @default.
- W4386558828 cites W2333898541 @default.
- W4386558828 cites W2335917381 @default.
- W4386558828 cites W2516171296 @default.
- W4386558828 cites W2531269403 @default.
- W4386558828 cites W2744225174 @default.
- W4386558828 cites W2751650523 @default.
- W4386558828 cites W2761740280 @default.
- W4386558828 cites W2773127260 @default.
- W4386558828 cites W2792681441 @default.
- W4386558828 cites W2797958658 @default.
- W4386558828 cites W2807649309 @default.
- W4386558828 cites W2908547368 @default.
- W4386558828 cites W2934884174 @default.
- W4386558828 cites W2967854325 @default.
- W4386558828 cites W2991792334 @default.
- W4386558828 cites W3000267525 @default.
- W4386558828 cites W3004146074 @default.
- W4386558828 cites W3011549369 @default.
- W4386558828 cites W3012480421 @default.
- W4386558828 cites W3012975398 @default.
- W4386558828 cites W3023274953 @default.
- W4386558828 cites W3024045996 @default.
- W4386558828 cites W3038023103 @default.
- W4386558828 cites W3092412842 @default.
- W4386558828 cites W3113531122 @default.
- W4386558828 cites W3158865467 @default.
- W4386558828 cites W3172337443 @default.
- W4386558828 cites W3172390983 @default.
- W4386558828 cites W3193587655 @default.
- W4386558828 cites W4200267402 @default.
- W4386558828 cites W4234473732 @default.
- W4386558828 cites W4241715524 @default.
- W4386558828 cites W4248292785 @default.
- W4386558828 cites W4294771078 @default.
- W4386558828 cites W4311974482 @default.
- W4386558828 cites W4313304549 @default.
- W4386558828 cites W4313890664 @default.
- W4386558828 cites W4315754639 @default.
- W4386558828 cites W4320494229 @default.
- W4386558828 cites W4323347983 @default.
- W4386558828 cites W4362589565 @default.
- W4386558828 cites W4366827458 @default.
- W4386558828 cites W4378226865 @default.
- W4386558828 cites W4380871005 @default.
- W4386558828 cites W4382181970 @default.
- W4386558828 cites W4383723780 @default.
- W4386558828 cites W4383814603 @default.
- W4386558828 cites W4383901264 @default.
- W4386558828 doi "https://doi.org/10.3390/cancers15184470" @default.
- W4386558828 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37760440" @default.
- W4386558828 hasPublicationYear "2023" @default.
- W4386558828 type Work @default.
- W4386558828 citedByCount "0" @default.
- W4386558828 crossrefType "journal-article" @default.
- W4386558828 hasAuthorship W4386558828A5004882510 @default.
- W4386558828 hasAuthorship W4386558828A5015116660 @default.
- W4386558828 hasAuthorship W4386558828A5019463160 @default.
- W4386558828 hasAuthorship W4386558828A5030516215 @default.
- W4386558828 hasAuthorship W4386558828A5044033060 @default.
- W4386558828 hasAuthorship W4386558828A5049884816 @default.
- W4386558828 hasAuthorship W4386558828A5052597738 @default.
- W4386558828 hasAuthorship W4386558828A5054335379 @default.
- W4386558828 hasAuthorship W4386558828A5071731375 @default.
- W4386558828 hasAuthorship W4386558828A5087796447 @default.